U.S. stocks closed slightly lower on Thursday after veering between gains and losses as investors gauged the latest round of ...

Wedbush says Tesla (TSLA) and its CEO Elon Musk are facing a defining chapter in their future and how the executive handles this over the next ...

As previously reported, Wedbush initiated coverage of Zenas BioPharma (ZBIO) with an Outperform rating and $35 price target The firm notes its ...

CME Group Solana futures are cash-settled and based on the CME CF Solana-Dollar Reference Rate, which serves as a once-a-day reference rate of the U.S. dollar price of SOL and is calculated daily at 4 ...

Investing.com -- Wedbush analyst Dan Ives sees Trump’s latest tariff policies as a significant near-term headwind for growth stocks but remains confident in the long-term strength of the AI-driven ...

On February 28, Daniel Ives from Wedbush maintained a “Buy” rating on the stock with a price target of $22.00. SoundHound AI, offering innovative voice and conversational AI solutions across ...

Wedbush analyst S. Basham now forecasts that the company will post earnings per share of $0.48 for the year, down from their prior forecast of $0.58. Wedbush has a “Neutral” rating and a $10. ...

Wedbush analysts called Palantir one of their "top names" to own in 2025 despite recent losses. Shares of Palantir have lost one-third of their value in the wake of a report last month that the ...